Berman Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $312K | Buy |
517
+113
| +28% | +$68.2K | 0.05% | 195 |
|
|
2021
Q2 | $225K | Sell |
404
-449
| -53% | -$250K | 0.04% | 215 |
|
|
2021
Q1 | $403K | Buy |
853
+732
| +605% | +$346K | 0.08% | 113 |
|
|
2020
Q4 | $58K | Sell |
121
-3
| -2% | -$1.44K | 0.01% | 368 |
|
|
2020
Q3 | $68K | Buy |
124
+1
| +0.8% | +$548 | 0.02% | 279 |
|
|
2020
Q2 | $76K | Buy |
123
+24
| +24% | +$14.8K | 0.02% | 263 |
|
|
2020
Q1 | $47K | Buy |
99
+46
| +87% | +$21.8K | 0.02% | 303 |
|
|
2019
Q4 | $19K | Hold |
53
| – | – | 0.01% | 553 |
|
|
2019
Q3 | $14K | Buy |
53
+12
| +29% | +$3.17K | ﹤0.01% | 624 |
|
|
2019
Q2 | $12K | Sell |
41
-83
| -67% | -$24.3K | ﹤0.01% | 672 |
|
|
2019
Q1 | $50K | Buy |
124
+22
| +22% | +$8.87K | 0.02% | 269 |
|
|
2018
Q4 | $37K | Buy |
+102
| New | +$37K | 0.01% | 286 |
|